1)Ajani JA:Standard chemotherapy for gastric carcinoma:is it a myth? J Clin Oncol 18:4001-4003, 2000
2)日本胃癌学会:胃癌治療ガイドライン第4版,金原出版,2014
3)Kinoshita T, Kinoshita T, Saiura A, et al:Multicentre analysis of long-term outcome after surgical resection of gastric cancer liver metastases. Br J Surg 102:102-107, 2015
4)Oki E, Tokunaga S, Emi Y, et al:Surgical Treatment of liver metastasis of gastric cancer:a retrospective multicenter cohort study(KSCC1302). Gastric Cancer 19:968-976, 2016
5)Tatsubayashi T, Tanizawa Y, Miki Y, et al:Treatment outcomes of hepatectomy for liver metastases of gastric cancer diagnosed using contrast-enhanced magnetic resonance imaging. Gastric Cancer 22:387-393, 2017
6)Tsuburaya A, Mizusawa J, Tanaka Y, et al:Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis. Br J Surg. 101:653-660, 2014
7)Kodera Y, Ishiyama A, Yoshikawa T, et al:Long-term follow up of patients who were positive for peritoneal lavage cytology:final report from the CCOG0301 study. Gastric Cancer 15:335-337, 2012
8)Fujitani K, Yang HK, Mizusawa J, et al:Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curative factor(REGATTA):a phase 3, randomised controlled trial. Lancet Oncol 17:309-318, 2016
9)小寺泰弘,神田光郎:胃がん.日本癌治療認定医機構教育委員会:がん治療認定医教育セミナーテキスト第10版,pp 132-137,2016
10)Fukuchi M, Ishiguro T, Ogata K, et al:Prognostic role of conversion surgery for unresectable gastric cancer. Ann Surg Oncol 22:3618-3624, 2015
11)Kinoshita J, Fushida S, Tsukada T, et al:Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage Ⅳ gastric cancer. Eur J Surg Oncol 41:1354-1360, 2015
12)Einama T, Abe H, Shichi S, et al:Long-term survival and prognosis associated with conversion surgery in patients with metastatic gastric cancer. Mol Clin Oncol 6:163-166, 2017
13)Mieno H, Yamashita K, Hosoda K, et al:Conversion surgery after combination chemotherapy of docetaxel, cisplatin and S-1(DCS)for far-advanced gastric cancer. Surg Today, in press
14)Sato Y, Ohnuma H, Nobuoka T, et al:Conversion therapy for inoperable advanced gastric cancer patients by docetaxel, cisplatin and S-1(DCS)chemotherapy:a multi-institutional retrospective study. Gastric Cancer 20:517-526, 2017
15)Kitayama J, Ishigami H, Yamaguchi H, et al:Salvage gastrectomy after intravenous and intraperitoneal paclitaxel(PTX)administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites. Ann Surg Oncol 21:539-546, 2014
16)Suzuki T, Tanabe K, Taomoto J, et al:Preliminary trial of adjuvant surgery for advanced gastric cancer. Oncol Lett 1:743-7, 2010
17)Kanda T, Yajima K, Kosugi S, et al:Gastrectomy as a secondary surgery for stage IV gastric cancer patients who underwent S-1-based chemotherapy:a multi-institute retrospective study. Gastric Cancer 15:235-244, 2012
18)Kodera Y:Neoadjuvant chemotherapy for gastric adenocarcinoma in Japan. Surg Today 47:899-907, 2017
19)Yoshikawa T, Sasako M, Yamamoto S, et al:Phase Ⅱ study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer. Br J Surg 96:1015-1022, 2009.
20)Ito S, Sano T, Mizusawa J, et al:A phase Ⅱ study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis:JCOG1002. Gastric Cancer 20:322-331, 2017
21)Yoshida K, Yamaguchi K, Okumura N, et al:Is conversion therapy possible in stage IV gastric cancer:the proposal of new biological categories of classification. Gastric Cancer 19:329-338, 2016